Skip to main content
OpenTrials
Completed

NCT Number: NCT05340244

GE CVUS Device Evaluation

The purpose of the study is to collect user feedback on the Vivid E95 ultrasound system and probes during clinical procedures on the device's intended population in order to optimize the device.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Echocardiography

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

The Children's Mercy Hospital

Kansas City, Missouri, 64108, United States

About this study

The purpose of the study is to collect user feedback on the Vivid E95 ultrasound system and probes during clinical procedures on the device's intended population in order to optimize the device. The primary objective of this study is to collect user feedback and de-identified images from the Vivid E95 ultrasound system and probes in TTE and TEE exams in a clinical setting. User feedback will include workflow, performance, user preference, image quality, device features, and open-ended feedback. The safety objective of this study is to collect safety information, including type and number of adverse events and device issues.

This is a pre-market, open label, prospective, non-randomized clinical research study conducted at one site in the United States. This study is not intended to support a comparative claim or test any hypotheses, such as superiority or non-inferiority. No clinical efficacy endpoints will be assessed.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Has a clinical indication for a TEE and/or TTE procedure with an ultrasound device
  • Has a weight of at least 5kg
  • Are able and willing to comply with study procedures
  • If less than 7 years old, has a parent or legally authorized representative able and willing to provide written consent to participate
  • If 7-17 years old, are able and willing to provide written assent to participate AND have a parent or legally authorized representative able and willing to provide written consent to participate
  • If 18 years old or older, are able and willing to provide written consent to participate

Exclusion criteria

  • Pregnant or suspected to be pregnant based on the opinion of a clinician investigator
  • Expected to be at increased risk due to study participation (e.g. due to sensitivities, relative or absolute contraindication to TEE), in the opinion of a clinician investigator
  • Previously participated in this study or are enrolled in another research study that could be expected to interfere with participation in study procedures
  • History of esophageal surgery or known vascular ring

Treatment and study plan

Investigational ultrasound exam

Device

Eligible subjects will be enrolled into the study and positioned for their ultrasound exam. Standard clinical practice procedures will be followed using the standard of care device at the site to complete the clinically indicated exams.

After the clinically indicated exam, portions of the TTE and/or TEE exam will be repeated with the investigational ultrasound device.

Primary outcomes

  1. Number of User Feedback Surveys

    Time frame: The total number of User Surveys will be reported. Surveys capture feedback from the device user across multiple subjects. The protocol did not require surveys be collected at specific timepoints. The device was used on each subject for about 15 minutes.

    The primary objective of this study is to collect user feedback from the investigational ultrasound system in TTE and TEE exams in a clinical setting. User Surveys consist of Likert scales and qualitative feedback and this data will not follow a statistical analysis plan.

  2. Number of De-identified Images

    Time frame: The total number of images collected will be reported. Multiple images are collected from each subject and the protocol does not require images to be collected at specific points in time. The device was used on each subject for about 15 minutes.

    The primary objective of this study is to collect de-identified images from the investigational ultrasound system in TTE and TEE exams in a clinical setting.

Other outcomes

  1. Number of Safety Events

    Time frame: The total number of adverse events will be reported. Subjects were monitored for adverse events throughout the duration (start to conclusion) of each investigational ultrasound exam, an average of 15 minutes per subject.

    The number of adverse events will be reported. No clinical efficacy endpoints will be assessed.

  2. Number of Device Issues

    Time frame: The total number of device issues will be reported. Study staff monitored for device issues throughout the duration (start to conclusion) of each investigational ultrasound exam, an average of 15 minutes per subject.

    The number of device issues will be reported. No clinical efficacy endpoints will be assessed.

Sponsors and collaborators

Lead sponsor

GE Healthcare

Industry

Registry information

Official study title

GE Cardiovascular Ultrasound Device Evaluation

Important dates

Study start
2022
Primary completion
2022
Study completion
2022
First posted
Apr 22, 2022
Registry last updated
Jan 10, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.